Attached files

file filename
EX-32.2 - EX-32.2 - AMPCO PITTSBURGH CORPap-ex322_9.htm
EX-32.1 - EX-32.1 - AMPCO PITTSBURGH CORPap-ex321_10.htm
EX-31.2 - EX-31.2 - AMPCO PITTSBURGH CORPap-ex312_8.htm
EX-31.1 - EX-31.1 - AMPCO PITTSBURGH CORPap-ex311_6.htm

Un

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021 

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number 1-898

 

AMPCO-PITTSBURGH CORPORATION

 

 

 

Pennsylvania

25-1117717

(State of

Incorporation)

(I.R.S. Employer

Identification No.)

726 Bell Avenue, Suite 301

Carnegie, Pennsylvania 15106

(Address of principal executive offices)

(412) 456-4400

(Registrant’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1 par value

AP

New York Stock Exchange

Series A Warrants to purchase shares of Common Stock

AP WS

NYSE American

   Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

   Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 

 

 

 

 

 

Large accelerated filer

Accelerated filer

Emerging growth company

 

 

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  

   Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

On May 3, 2021, 18,856,736 common shares were outstanding.

 

 

 

 


 

AMPCO-PITTSBURGH CORPORATION

INDEX

 

 

 

 

 

Page No.

Part I 

 

Financial Information:

 

 

 

 

 

 

 

 

 

 

 

Item 1 

 

Financial Statements (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets – March 31, 2021 and December 31, 2020

 

3

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Operations – Three Months Ended March 31, 2021 and 2020

 

4

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income (Loss) – Three Months Ended March 31, 2021 and 2020

 

 

5

 

 

 

 

Condensed Consolidated Statements of Shareholders’ Equity – Three Months Ended March 31, 2021 and 2020

 

6

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2021 and 2020

 

7

 

 

 

 

 

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

8

 

 

 

 

 

 

 

 

 

Item 2 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

21

 

 

 

 

 

 

 

 

 

Item 3 

 

Quantitative and Qualitative Disclosures About Market Risk

 

27

 

 

 

 

 

 

 

 

 

Item 4 

 

Controls and Procedures

 

27

 

 

 

 

 

 

 

Part II 

 

Other Information:

 

 

 

 

 

 

 

 

 

Item 1

 

Legal Proceedings

 

28

 

 

 

 

 

 

 

 

 

Item 1A 

 

Risk Factors

 

28

 

 

 

 

 

 

 

 

 

Item 6 

 

Exhibits

 

29

 

 

 

 

 

 

 

Signatures

 

30

 

 

 

 

 

 

 

 

2


 

PART I – FINANCIAL INFORMATION

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(in thousands, except par value)

 

 

March 31,

2021

 

 

December 31,

2020

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

18,251

 

 

$

16,842

 

Receivables, less allowance for doubtful accounts of $935 in 2021 and $1,131 in 2020

 

 

69,947

 

 

 

60,366

 

Inventories

 

 

75,793

 

 

 

73,243

 

Insurance receivable – asbestos

 

 

16,000

 

 

 

16,000

 

Other current assets

 

 

6,076

 

 

 

5,381

 

Total current assets

 

 

186,067

 

 

 

171,832

 

Property, plant and equipment, net

 

 

157,901

 

 

 

162,098

 

Operating lease right-of-use assets

 

 

4,273

 

 

 

4,344

 

Insurance receivable – asbestos

 

 

99,862

 

 

 

101,937

 

Deferred income tax assets

 

 

2,493

 

 

 

2,493

 

Intangible assets, net

 

 

6,702

 

 

 

7,217

 

Investments in joint ventures

 

 

2,175

 

 

 

2,175

 

Other noncurrent assets

 

 

11,821

 

 

 

11,112

 

Total assets

 

$

471,294

 

 

$

463,208

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

34,824

 

 

$

26,678

 

Accrued payrolls and employee benefits

 

 

20,116

 

 

 

19,304

 

Debt – current portion

 

 

14,584

 

 

 

12,436

 

Operating lease liabilities – current portion

 

 

686

 

 

 

674

 

Asbestos liability – current portion

 

 

22,000

 

 

 

22,000

 

Other current liabilities

 

 

26,928

 

 

 

24,240

 

Total current liabilities

 

 

119,138

 

 

 

105,332

 

Employee benefit obligations

 

 

79,272

 

 

 

81,832

 

Asbestos liability

 

 

154,856

 

 

 

158,196

 

Long-term debt

 

 

21,909

 

 

 

24,807

 

Noncurrent operating lease liabilities

 

 

3,587

 

 

 

3,670

 

Deferred income tax liabilities

 

 

1,417

 

 

 

1,403

 

Other noncurrent liabilities

 

 

2,632

 

 

 

2,969

 

Total liabilities

 

 

382,811

 

 

 

378,209

 

Commitments and contingent liabilities (Note 8)

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

Common stock – par value $1; authorized 40,000 shares;

    issued and outstanding 18,857 shares in 2021 and 18,312 shares in 2020

 

 

18,857

 

 

 

18,312

 

Additional paid-in capital

 

 

173,401

 

 

 

170,318

 

Retained deficit

 

 

(43,204

)

 

 

(43,371

)

Accumulated other comprehensive loss

 

 

(69,187

)

 

 

(68,695

)

Total Ampco-Pittsburgh shareholders’ equity

 

 

79,867

 

 

 

76,564

 

Noncontrolling interest

 

 

8,616

 

 

 

8,435

 

Total shareholders’ equity

 

 

88,483

 

 

 

84,999

 

Total liabilities and shareholders’ equity

 

$

471,294

 

 

$

463,208

 

See Notes to Condensed Consolidated Financial Statements.

 

3


 

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

(in thousands, except per share amounts)

 

 

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

 

2021

 

 

2020

 

Net sales

 

 

 

 

 

$

86,800

 

 

$

91,063

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Costs of products sold (excluding depreciation and amortization)

 

 

 

 

 

 

69,588

 

 

 

70,160

 

Selling and administrative

 

 

 

 

 

 

11,558

 

 

 

11,830

 

Depreciation and amortization

 

 

 

 

 

 

4,743

 

 

 

4,699

 

Loss on disposal of assets

 

 

 

 

 

 

4

 

 

 

23

 

Total operating costs and expenses

 

 

 

 

 

 

85,893

 

 

 

86,712

 

Income from operations

 

 

 

 

 

 

907

 

 

 

4,351

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Investment-related income

 

 

 

 

 

 

18

 

 

 

4

 

Interest expense

 

 

 

 

 

 

(895

)

 

 

(1,216

)

Other income (expense) – net

 

 

 

 

 

 

665

 

 

 

(1,320

)

Total other income (expense)

 

 

 

 

 

 

(212

)

 

 

(2,532

)

Income before income taxes

 

 

 

 

 

 

695

 

 

 

1,819

 

Income tax (provision) benefit

 

 

 

 

 

 

(381

)

 

 

2,783

 

Net income

 

 

 

 

 

 

314

 

 

 

4,602

 

Less: Net income attributable to noncontrolling interest

 

 

 

 

 

 

147

 

 

 

460

 

Net income attributable to Ampco-Pittsburgh

 

 

 

 

 

$

167

 

 

$

4,142

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share attributable to Ampco-Pittsburgh common shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

 

 

$

0.01

 

 

$

0.33

 

Diluted

 

 

 

 

 

$

0.01

 

 

$

0.33

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

 

 

 

18,637

 

 

 

12,656

 

Diluted

 

 

 

 

 

 

20,669

 

 

 

12,672

 

 

See Notes to Condensed Consolidated Financial Statements.

 

4


 

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

(in thousands)

 

 

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

 

2021

 

 

2020

 

Net income

 

 

 

 

 

$

314

 

 

$

4,602

 

Other comprehensive (loss) income, net of income tax where applicable:

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments for changes in:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

 

 

 

 

(856

)

 

 

(4,882

)

Unrecognized employee benefit costs (including effects of foreign currency translation)

 

 

 

 

 

 

57

 

 

 

693

 

Fair value of cash flow hedges

 

 

 

 

 

 

310

 

 

 

(578

)

Reclassification adjustments for items included in net income:

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of unrecognized employee benefit costs

 

 

 

 

 

 

362

 

 

 

385

 

Realized gains from settlement of cash flow hedges

 

 

 

 

 

 

(331

)

 

 

(15

)

Other comprehensive loss

 

 

 

 

 

 

(458

)

 

 

(4,397

)

Comprehensive (loss) income

 

 

 

 

 

 

(144

)

 

 

205

 

Less: Comprehensive income attributable to noncontrolling interest

 

 

 

 

 

 

181

 

 

 

338

 

Comprehensive loss attributable to Ampco-Pittsburgh

 

 

 

 

 

$

(325

)

 

$

(133

)

 

See Notes to Condensed Consolidated Financial Statements.


5


 

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(UNAUDITED)

(in thousands)

 

Three Months Ended March 31, 2021

 

Common

Stock

 

 

Additional

Paid-in

Capital

 

 

Retained

Deficit

 

 

Accumulated

Other

Comprehensive

Loss

 

 

Noncontrolling

Interest

 

 

Total

 

Balance at January 1, 2021

 

$

18,312

 

 

$

170,318

 

 

$

(43,371

)

 

$

(68,695

)

 

$

8,435

 

 

$

84,999

 

Stock-based compensation

 

 

 

 

 

 

546

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

546

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

167

 

 

 

 

 

 

 

147

 

 

 

314

 

Other comprehensive (loss) income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(492

)

 

 

34

 

 

 

(458

)

Comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

181

 

 

 

(144

)

Shareholder exercise of warrants (Note 9)

 

 

539

 

 

 

2,562

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,101

 

Issuance of common stock excluding excess tax benefits of $0

 

 

6

 

 

 

(25

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(19

)

Balance at March 31, 2021

 

$

18,857

 

 

$

173,401

 

 

$

(43,204

)

 

$

(69,187

)

 

$

8,616

 

 

$

88,483

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2020

 

$

12,652

 

 

$

156,251

 

 

$

(51,341

)

 

$

(68,662

)

 

$

6,716

 

 

$

55,616

 

Stock-based compensation

 

 

 

 

 

 

364

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

364

 

Comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

4,142

 

 

 

 

 

 

 

460

 

 

 

4,602

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,275

)

 

 

(122

)

 

 

(4,397

)

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

338

 

 

 

205

 

Issuance of common stock excluding excess tax benefits of $0

 

 

7

 

 

 

(13

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6

)

Balance at March 31, 2020

 

$

12,659

 

 

$

156,602

 

 

$

(47,199

)

 

$

(72,937

)

 

$

7,054

 

 

$

56,179

 

 

See Notes to Condensed Consolidated Financial Statements.

6


S

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(in thousands)

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Net cash flows provided by operating activities

 

$

1,858

 

 

$

12,605

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(2,378

)

 

 

(1,912

)

Purchases of long-term marketable securities

 

 

(1

)

 

 

(2

)

Proceeds from sale of long-term marketable securities

 

 

76

 

 

 

71

 

Net cash flows used in investing activities

 

 

(2,303

)

 

 

(1,843

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Repayment of debt

 

 

(500

)

 

 

(335

)

Proceeds from Revolving Credit and Security Agreement

 

 

3,571

 

 

 

853

 

Payments on Revolving Credit and Security Agreement

 

 

(4,000

)

 

 

(3,662

)

Proceeds from shareholder exercise of warrants (Note 9)

 

 

3,101

 

 

 

0

 

Net cash flows provided by (used in) financing activities

 

 

2,172

 

 

 

(3,144

)

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(318

)

 

 

(636

)

 

 

 

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

 

1,409

 

 

 

6,982

 

Cash and cash equivalents at beginning of period

 

 

16,842

 

 

 

6,960

 

Cash and cash equivalents at end of period

 

$

18,251

 

 

$

13,942

 

 

 

 

 

 

 

 

 

 

Supplemental information:

 

 

 

 

 

 

 

 

Income tax payments

 

$

274

 

 

$

312

 

Interest payments

 

$

607

 

 

$

874

 

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment included in accounts payable

 

$

665

 

 

$

878

 

Finance lease right-of-use assets exchanged for lease liabilities

 

$

0

 

 

$

382

 

Operating lease right-of-use assets exchanged for lease liabilities

 

$

53

 

 

$

610

 

 

See Notes to Condensed Consolidated Financial Statements.

 

7


 

AMPCO-PITTSBURGH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(in thousands, except share amounts)

 

Overview of the Business

Ampco-Pittsburgh Corporation (the “Corporation”) manufactures and sells highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments – the Forged and Cast Engineered Products (“FCEP”) segment and the Air and Liquid Processing segment. This segment presentation is consistent with how the Corporation’s chief operating decision maker evaluates financial performance and makes resource allocation and strategic decisions about the business.

The Segments

The FCEP segment produces forged hardened steel rolls, cast rolls and open-die forged products. Forged hardened steel rolls are used primarily in cold rolling mills by producers of steel, aluminum and other metals. Cast rolls, which are produced in a variety of iron and steel qualities, are used mainly in hot and cold strip mills, medium/heavy section mills and plate mills. Forged engineered products (“FEP”) are principally sold to customers in the steel distribution market, oil and gas industry and the aluminum and plastic extrusion industries. The segment has operations in the United States, England, Sweden, Slovenia, and an equity interest in three joint venture companies in China. Collectively, the segment primarily competes with European, Asian and North and South American companies in both domestic and foreign markets and distributes a significant portion of its products through sales offices located throughout the world.

The Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling and Buffalo Pumps, all divisions of Air & Liquid Systems Corporation (“Air & Liquid”), a wholly owned subsidiary of the Corporation. Aerofin produces custom-engineered finned tube heat exchange coils and related heat transfer products for a variety of industries including OEM/commercial, nuclear power generation and industrial manufacturing. Buffalo Air Handling produces large custom-designed air handling systems for institutional (e.g., hospital, university), pharmaceutical and general industrial building markets. Buffalo Pumps manufactures centrifugal pumps for the fossil-fueled power generation, marine defense and industrial refrigeration industries. The segment has operations in Virginia and New York with headquarters in Carnegie, Pennsylvania. The segment distributes a significant portion of its products through a common independent group of sales offices located throughout the United States and Canada.

COVID-19

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency caused by a new strain of the coronavirus (“COVID-19”) and advised of the risks to the international community as the virus spread globally. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in exposure globally. In response, many state and local governments required the closure of various businesses. The U.S. Department of Homeland Security, however, provided guidance identifying the Corporation’s domestic businesses as critical infrastructure industries, essential to the economic prosperity, security and continuity of the United States, which provides exceptions to certain closures mandated by state and local governments and permits businesses to continue operations during such an order. Despite the designation, the Corporation has had to periodically and temporarily idle certain operations of its FCEP segment and, consequently, furlough certain of its employees in response to market conditions. It also has experienced, and may continue to experience, customer-requested delays of deliveries or, potentially, cancellation of orders.

It is difficult to isolate the impact of the pandemic on the Corporation’s operating results, particularly in relation to the unabsorbed costs resulting from the periodic and temporary idling of certain of the Corporation’s forged and cast roll operations and furloughing of employees. In addition, the Corporation is uncertain of the full effect the pandemic will have on it for the longer term since the scope and duration of the pandemic is unknown, and evolving factors such as the level and timing of vaccine distribution across the world and the extent of any resurgences of the virus or emergence of new variants will impact the stability of the economic recovery and growth. The extent to which the operations of the Corporation, and the operations of its customers, may be adversely impacted by the COVID-19 pandemic will depend largely on these future developments. The Corporation may experience long-term disruptions to its operations resulting from changes in government policy or guidance; quarantines of employees, customers and suppliers in areas affected by the pandemic; and closures of businesses or manufacturing facilities critical to its business or supply chains. It may also incur higher write-offs of accounts receivables and impairment charges on its asset values, including property, plant and equipment and intangible assets. The Corporation is actively monitoring, and will continue to actively monitor, the pandemic and the potential impact on its operations, financial condition, liquidity, suppliers, industry, and workforce.

8


In response to the pandemic, the United States federal government enacted the “Coronavirus Aid, Relief, and Economic Security (CARES) Act” into law on March 27, 2020. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferral of employer-side social security payments and contributions to employee benefit plans, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. Subsequently, on March 11, 2021, the “American Rescue Plan (“ARP”) Act of 2021” was enacted into law, providing the next phase of economic relief as a result of the COVID-19 pandemic. The ARP Act, among other things, extends provision relating to refundable payroll tax credits and deferral of contributions to employee benefit plans. Similar programs have been offered in certain of the foreign jurisdictions in which the Corporation operates, including subsidies and reimbursement of certain employee-related costs. While the Corporation has taken, and intends to continue to take, advantage of various provisions of the CARES Act, the ARP Act and other similar programs offered domestically and in foreign jurisdictions in which the Corporation operates, where possible, it is unable to determine what impact those provisions may have on its consolidated financial statements in the future.

1.

Unaudited Condensed Consolidated Financial Statements

The condensed consolidated balance sheet as of March 31, 2021, the condensed consolidated statements of operations, comprehensive income (loss), shareholders’ equity, and cash flows for the three months ended March 31, 2021, and 2020, have been prepared by the Corporation without audit. In the opinion of management, all adjustments, consisting of only normal and recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the periods presented, have been made. The results of operations for the three months ended March 31, 2021, are not necessarily indicative of the operating results expected for the full year.

Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted.

Recently Implemented Accounting Pronouncements

In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes (Topic 740). ASU 2019-12 is intended to simplify the accounting for income taxes including removing the exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items such as other comprehensive income, accounting for franchise or similar tax, and requiring an entity reflect the effect of an enacted change in tax laws or rates in the interim period that includes the enactment date. The guidance became effective for the Corporation on January 1, 2021, and did not impact the Corporation’s financial position, operating results or liquidity.

Recently Issued Accounting Pronouncements 

In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. ASU 2020-06 requires entities to provide expanded disclosures about the terms and features of convertible instruments and amends certain guidance in ASC 260, Earnings per Share, relating to the computation of earnings per share for convertible instruments and contracts in an entity’s own equity. The guidance becomes effective for the Corporation on January 1, 2024, with early adoption of all amendments in the same period permitted. The Corporation is currently evaluating the impact the guidance will have on its consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional guidance for a limited period of time for applying generally accepted accounting principles to modifications of contracts, hedging relationships, and other transactions that reference LIBOR or another rate that will be discontinued by reference rate reform if certain criteria are met. The optional guidance is available as of March 12, 2020, through December 31, 2022. To date, no contracts have been required to be modified as a result of reference rate reform. The Corporation is currently evaluating the impact the guidance will have on its financial position, operating results and liquidity if such an event occurs in the future and the Corporation chooses to avail itself of the optional guidance.

In September 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses, which adds a new impairment model, known as the current expected credit loss (“CECL”) model, that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes an allowance for its estimate of expected credit losses and applies it to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. The guidance originally became effective for the Corporation on January 1, 2020, however, since the Corporation met the definition of a Smaller Reporting Company, as defined by the Securities Exchange Commission, the effective date was subsequently revised to fiscal years beginning after December 15, 2022. The Corporation is currently evaluating the impact the guidance will have on its financial position and operating results. It will not, however, affect the Corporation’s liquidity.

9


2.

Inventories

At March 31, 2021, and December 31, 2020, 35% of the inventories were valued on the LIFO method with the remaining inventories valued on the FIFO method. Inventories were comprised of the following:

 

 

 

March 31,

2021

 

 

December 31,

2020

 

Raw materials

 

$

15,824

 

 

$

17,893

 

Work-in-process

 

 

34,139

 

 

 

31,568

 

Finished goods

 

 

14,791

 

 

 

12,466

 

Supplies

 

 

11,039

 

 

 

11,316

 

Inventories

 

$

75,793

 

 

$

73,243

 

 

3.

Property, Plant and Equipment

Property, plant and equipment were comprised of the following:

 

 

March 31,

2021

 

 

December 31,

2020

 

Land and land improvements

 

$

10,375

 

 

$

10,473

 

Buildings

 

 

63,547

 

 

 

63,765

 

Machinery and equipment

 

 

340,650

 

 

 

339,203

 

Construction-in-process

 

 

4,005

 

 

 

4,896

 

Other

 

 

6,870

 

 

 

6,870

 

 

 

 

425,447

 

 

 

425,207

 

Accumulated depreciation and amortization

 

 

(267,546

)

 

 

(263,109

)

Property, plant and equipment, net

 

$

157,901

 

 

$

162,098

 

 

The majority of the assets of the Corporation, except real property including the land and building of Union Electric Steel UK Limited, an indirect subsidiary of the Corporation (“UES-UK”), is pledged as collateral for the Corporation’s revolving credit facility (Note 6). Land and buildings of UES-UK equal to $2,921 (£2,122) at March 31, 2021, are held as collateral by the trustees of the UES-UK defined benefit pension plan (Note 7). The gross value of finance lease right-of-use assets and the related accumulated amortization equaled $2,897 and $1,023, respectively, as of March 31, 2021, and $3,430 and $1,222, respectively, at December 31, 2020. Amortization on assets under finance leases approximated $118 and $70 for the three months ended March 31, 2021, and 2020, respectively.

4.

Intangible Assets

Intangible assets were comprised of the following:

 

 

March 31,

2021

 

 

December 31,

2020

 

Customer relationships

 

$

6,017

 

 

$

6,191

 

Developed technology

 

 

4,283

 

 

 

4,457

 

Trade name

 

 

2,509

 

 

 

2,646

 

 

 

 

12,809

 

 

 

13,294

 

Accumulated amortization

 

 

(6,107

)

 

 

(6,077

)

Intangible assets, net

 

$

6,702

 

 

$

7,217

 

The following summarizes changes in intangible assets:

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

2021

 

 

2020

 

Balance at beginning of the period

 

 

 

 

$

7,217

 

 

$

7,625

 

Amortization of intangible assets

 

 

 

 

 

(249

)

 

 

(277

)

Other, primarily impact from changes in foreign currency exchange rates

 

 

 

 

 

(266

)

 

 

(362

)

Balance at end of the period

 

 

 

 

$

6,702

 

 

$

6,986

 

 

10


 

5.

Other Current Liabilities

Other current liabilities were comprised of the following:

 

 

March 31,

2021

 

 

December 31,

2020

 

Customer-related liabilities

 

$

15,910

 

 

$

16,144

 

Accrued interest payable

 

 

2,114

 

 

 

2,131

 

Accrued sales commissions

 

 

1,680

 

 

 

1,419

 

Other

 

 

7,224

 

 

 

4,546

 

Other current liabilities

 

$

26,928

 

 

$

24,240

 

 

Included in customer-related liabilities are costs expected to be incurred with respect to product warranties and customer deposits. The Corporation provides a limited warranty on its products, known as assurance type warranties, and may issue credit notes or replace products free of charge for valid claims. A warranty is considered an assurance type warranty if it provides the customer with assurance that the product will function as intended. Historically, warranty claims have been insignificant. The Corporation records a provision for product warranties at the time the underlying sale is recorded. The provision is based on historical experience as a percent of sales adjusted for potential claims when a liability is probable and for known claims.

Changes in the liability for product warranty claims consisted of the following:

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

2021

 

 

2020

 

Balance at beginning of the period

 

 

 

 

$

8,105

 

 

$

9,065

 

Satisfaction of warranty claims

 

 

 

 

 

(650

)

 

 

(1,187

)

Provision for warranty claims

 

 

 

 

 

786

 

 

 

1,114

 

Other, primarily impact from changes in foreign currency exchange rates

 

 

 

 

 

(84

)

 

 

(329

)

Balance at end of the period

 

 

 

 

$

8,157

 

 

$

8,663

 

 

Customer deposits represent amounts collected from, or invoiced to, a customer in advance of revenue recognition, and are recorded as other current liabilities on the condensed consolidated balance sheet. The liability for customer deposits is reversed when the Corporation satisfies its performance obligations and control of the inventory transfers to the customer, typically when title transfers. Performance obligations related to customer deposits are expected to be satisfied in less than one year.

Changes in customer deposits consisted of the following:

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

2021

 

 

2020

 

Balance at beginning of the period

 

 

 

 

$

6,507

 

 

$

4,895

 

Satisfaction of performance obligations

 

 

 

 

 

(4,035

)

 

 

(4,025

)

Receipt of additional deposits

 

 

 

 

 

4,072

 

 

 

5,586

 

Other, primarily impact from changes in foreign currency exchange rates

 

 

 

 

 

(33

)

 

 

(74

)

Balance at end of the period

 

 

 

 

$

6,511

 

 

$

6,382

 

 

6.

Debt

Borrowings consisted of the following:

 

 

March 31,

2021

 

 

December 31,

2020

 

Revolving Credit and Security Agreement

 

$

5,571

 

 

$

6,000

 

Sale and leaseback financing obligation

 

 

20,088

 

 

 

19,931

 

Industrial Revenue Bonds

 

 

9,191

 

 

 

9,191

 

Minority shareholder loan

 

 

747

 

 

 

1,056

 

Finance lease liabilities

 

 

896

 

 

 

1,065

 

Outstanding borrowings

 

 

36,493

 

 

 

37,243

 

Debt – current portion

 

 

(14,584

)

 

 

(12,436

)

Long-term debt

 

$

21,909

 

 

$

24,807

 

11


 

Revolving Credit and Security Agreement

On May 20, 2016, the Corporation became a party to a Revolving Credit and Security Agreement, which has been amended periodically (collectively, with the original and amended agreements, the “Amended Credit Agreement”). The Amended Credit Agreement is with a syndicate of banks and provides for borrowings not to exceed $92,500. The Amended Credit Agreement includes sublimits for letters of credit not to exceed $40,000 and European borrowings not to exceed $15,000. The maturity date for the Amended Credit Agreement is May 20, 2022, and, subject to other terms and conditions of the Amended Credit Agreement, would become due on that date.

Availability under the Amended Credit Agreement is based on eligible accounts receivable, inventory and fixed assets. Amounts outstanding under the credit facility bear interest, at the Corporation’s option, at either (i) LIBOR plus an applicable margin ranging between 2.75% to 3.25% based on the quarterly average excess availability with LIBOR set at a minimum of 0.75% or (ii) the base rate plus an applicable margin ranging between 1.75% to 2.25% based on the quarterly average excess availability. Additionally, the Corporation is required to pay a commitment fee ranging between 0.25% and 0.375% based on the daily unused portion of the credit facility. As of March 31, 2021, the Corporation had outstanding borrowings under the Amended Credit Agreement of $5,571. The average interest rate was approximately 4% for the three months ended March 31, 2021, and 2020. Additionally, the Corporation utilizes a portion of the credit facility for letters of credit (Note 8). As of March 31, 2021, remaining availability under the Amended Credit Agreement approximated $46,800, net of standard availability reserves.

Borrowings outstanding under the Amended Credit Agreement are collateralized by a first priority perfected security interest in substantially all assets of the Corporation and its subsidiaries (other than real property). Additionally, the Amended Credit Agreement contains customary affirmative and negative covenants and limitations, including, but not limited to, investments in certain of its subsidiaries, payment of dividends, incurrence of additional indebtedness, and acquisitions and divestures. The Corporation must also maintain a certain level of excess availability. The Corporation was in compliance with the applicable bank covenants as of March 31, 2021.

Sale and Leaseback Financing Obligation

In September 2018, Union Electric Steel Corporation (“UES”), an indirect subsidiary of the Corporation, completed a sale and leaseback financing transaction for certain of its real property, including its manufacturing facilities in Valparaiso, Indiana and Burgettstown, Pennsylvania, and its manufacturing facility and corporate headquarters located in Carnegie, Pennsylvania (the “Properties”). Simultaneously with the sale, UES entered into a lease agreement pursuant to which UES leased the Properties from the buyer. The lease provides for an initial term of 20 years; however, UES may extend the lease for four successive periods of five years each. If fully extended, the lease would expire in September 2058. UES also has the option to repurchase the Properties, which it may exercise in 2025, for a price equal to the greater of (i) their Fair Market Value, or (ii) 115% of Lessor’s Total Investment for the Facilities, with such terms defined in the lease agreement. The effective interest rate approximated 8% for the three months ended March 31, 2021, and 2020.

Industrial Revenue Bonds (“IRBs”)

The Corporation has two IRBs outstanding: (i) $7,116 taxable IRB maturing in 2027 and (ii) $2,075 tax-exempt IRB maturing in 2029. The IRBs are remarketed periodically. If the IRBs are not able to be remarketed, although considered remote by the Corporation and its bankers, the bondholders can seek reimbursement immediately from the letters of credit which serve as collateral for the bonds. Accordingly, the IRBs are recorded as current debt.

7.

Pension and Other Postretirement Benefits

Contributions to the Corporation’s employee benefit plans are as follows:

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

U.S. defined benefit pension plans

 

$

0

 

 

$

281

 

Foreign defined benefit pension plans

 

 

171

 

 

 

105

 

Other postretirement benefits (e.g., net payments)

 

 

182

 

 

 

432

 

U.K. defined contribution pension plan

 

 

82

 

 

 

80

 

U.S. defined contribution plan

 

 

1,402

 

 

 

1,377

 

12


 

Net periodic pension and other postretirement benefit costs include the following components:

 

 

 

 

Three Months Ended March 31,

 

U.S. Defined Benefit Pension Plans

 

 

 

 

 

2021

 

 

2020

 

Service cost

 

 

 

 

 

$

57

 

 

$

58

 

Interest cost

 

 

 

 

 

 

1,471

 

 

 

1,836

 

Expected return on plan assets

 

 

 

 

 

 

(3,348

)

 

 

(3,199

)

Amortization of prior service cost (credit)

 

 

 

 

 

 

6

 

 

 

(3

)

Amortization of actuarial loss

 

 

 

 

 

 

574

 

 

 

583

 

Net benefit income

 

 

 

 

 

$

(1,240

)

 

$

(725

)

 

 

 

 

 

Three Months Ended March 31,

 

Foreign Defined Benefit Pension Plans

 

 

 

 

 

2021

 

 

2020

 

Service cost

 

 

 

 

 

$

87

 

 

$

105

 

Interest cost

 

 

 

 

 

 

208

 

 

 

263

 

Expected return on plan assets

 

 

 

 

 

 

(485

)

 

 

(494

)

Amortization of prior service credit

 

 

 

 

 

 

(77

)

 

 

(72

)

Amortization of actuarial loss

 

 

 

 

 

 

162

 

 

 

176

 

Net benefit income

 

 

 

 

 

$

(105

)

 

$

(22

)

 

 

 

 

 

Three Months Ended March 31,

 

Other Postretirement Benefit Plans

 

 

 

 

 

2021

 

 

2020

 

Service cost

 

 

 

 

 

$

56

 

 

$

59

 

Interest cost

 

 

 

 

 

 

70

 

 

 

84

 

Amortization of prior service credit

 

 

 

 

 

 

(254

)

 

 

(254

)

Amortization of actuarial gain

 

 

 

 

 

 

(35

)

 

 

(45

)

Net benefit income

 

 

 

 

 

$

(163

)

 

$

(156

)

 

8.

Commitments and Contingent Liabilities

Outstanding standby and commercial letters of credit as of March 31, 2021, equaled $14,352, the majority of which serves as collateral for the IRB debt. Outstanding surety bonds as of March 31, 2021, approximated $4,000 (SEK 33,900), which guarantee certain obligations under a credit insurance arrangement for certain of the Corporation’s foreign pension commitments.

At March 31, 2021, the Corporation had purchase commitments for expected future capital expenditures of approximately $3,700, which are anticipated to be spent over the next 12-18 months.

See Note 11 for derivative instruments, Note 15 for litigation and Note 16 for environmental matters.

9.

Equity Rights Offering

In September 2020, the Corporation completed an equity rights offering, issuing 5,507,889 shares of its common stock and 12,339,256 Series A warrants to existing shareholders for total gross proceeds of $19,279. The shares of common stock and warrants are classified as equity instruments in the condensed consolidated statement of shareholders’ equity. Each Series A warrant provides the holder with the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668, or $5.75 per whole share of common stock, and expires on August 1, 2025. Stock issuance costs equaled $1,140 and were recorded against the proceeds in additional paid in capital. In 2021, the Corporation received proceeds of $3,101 from shareholders who exercised 1,208,192 Series A warrants, equating to the issuance of 539,336 common shares.

 


13


 

10.

Accumulated Other Comprehensive Loss

Net change and ending balances for the various components of accumulated other comprehensive loss as of and for the three months ended March 31, 2021, and 2020, are summarized below. All amounts are net of tax, where applicable.

 

 

Foreign

Currency

Translation

 

 

Unrecognized

Employee

Benefit Costs

 

 

Cash Flow

Hedges

 

 

Total

Accumulated Other

Comprehensive Loss

 

 

Less:

Noncontrolling

Interest

 

 

Accumulated Other

Comprehensive Loss

Attributable to Ampco-Pittsburgh

 

Balance at January 1, 2021

 

$

(11,371

)

 

$

(57,652

)

 

$

589

 

 

$

(68,434

)

 

$

261

 

 

$

(68,695

)

Net change

 

 

(856

)

 

 

419

 

 

 

(21

)

 

 

(458

)

 

 

34

 

 

 

(492

)

Balance at March 31, 2021

 

$

(12,227

)

 

$

(57,233

)

 

$

568

 

 

$

(68,892

)

 

$

295

 

 

$

(69,187

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2020

 

$

(18,352

)

 

$

(50,859

)

 

$

291

 

 

$

(68,920

)

 

$

(258

)

 

$

(68,662

)

Net change

 

 

(4,882

)

 

 

1,078

 

 

 

(593

)

 

 

(4,397

)

 

 

(122

)

 

 

(4,275

)

Balance at March 31, 2020

 

$

(23,234

)

 

$

(49,781

)

 

$

(302

)

 

$

(73,317

)

 

$

(380

)

 

$

(72,937

)

The following summarizes the line items affected on the condensed consolidated statements of operations for components reclassified from accumulated other comprehensive loss. Amounts in parentheses represent credits to net income. Amounts are after tax, where applicable. Certain amounts have no tax effect due to the Corporation having a valuation allowance recorded against the deferred income tax assets for the jurisdiction where the income or expense is recognized. Foreign currency translation adjustments exclude the effect of income taxes since earnings of non-U.S. subsidiaries are deemed to be reinvested for an indefinite period of time.

 

 

 

 

Three Months Ended March 31,

 

 

 

 

2021

 

 

2020

 

Amortization of unrecognized employee benefit costs:

 

 

 

 

 

 

 

 

 

Other income

 

 

$

376

 

 

$

385

 

Income tax provision

 

 

 

(14

)

 

 

0

 

Net of tax

 

 

$

362

 

 

$

385

 

Realized gains from settlement of cash flow hedges:

 

 

 

 

 

 

 

 

 

Depreciation and amortization (foreign currency purchase contracts)

 

 

$

(7

)

 

$

(7

)

Costs of products sold (excluding depreciation and amortization) (futures contracts – copper and aluminum)

 

 

 

(324

)

 

 

(8

)

Total before income tax

 

 

 

(331

)

 

 

(15

)

Income tax provision

 

 

 

0

 

 

 

0

 

Net of tax

 

 

$

(331

)

 

$

(15

)

 

11.

Derivative Instruments

Certain of the Corporation’s operations are subject to risk from exchange rate fluctuations in connection with sales in foreign currencies. To minimize this risk, foreign currency sales contracts are entered into which are designated as cash flow or fair value hedges. As of March 31, 2021, approximately $4,694 of anticipated foreign-denominated sales has been hedged, which is covered by fair value contracts settling at various dates through January 2022.

Additionally, certain divisions of the Air and Liquid Processing segment are subject to risk from increases in the price of commodities (copper and aluminum) used in the production of inventory. To minimize this risk, futures contracts are entered into which are designated as cash flow hedges. At March 31, 2021, approximately 34%, or $2,200, of anticipated copper purchases over the next seven months and 56%, or $512, of anticipated aluminum purchases over the next six months are hedged.

The Corporation previously entered into foreign currency purchase contracts to manage the volatility associated with Euro-denominated progress payments to be made for certain machinery and equipment. As of December 31, 2010, all contracts had been settled and the underlying fixed assets were placed in service.

No portion of the existing cash flow or fair value hedges is considered to be ineffective, including any ineffectiveness arising from the unlikelihood of an anticipated transaction to occur. Additionally, no amounts have been excluded from assessing the effectiveness of a hedge.

14


The Corporation previously entered into purchase commitments to cover a portion of its anticipated natural gas usage for one of its subsidiaries. The commitments qualified as normal purchases and, accordingly, were not reflected on the condensed consolidated balance sheet. As of March 31, 2021, no purchase commitments for anticipated natural gas usage are outstanding. Purchases of natural gas under previously existing commitments equaled $388 for the three months ended March 31, 2020. There were no such purchases of natural gas under previously existing commitments for the three months ended March 31, 2021.

The Corporation does not enter into derivative transactions for speculative purposes and, therefore, holds no derivative instruments for trading purposes.

Losses on foreign exchange transactions included in other income (expense) equaled $(1,221) and $(1,731) for the three months ended March 31, 2021, and 2020, respectively.

The location and fair value of the foreign currency sales contracts recorded on the condensed consolidated balance sheets were as follows:

 

 

Location

 

March 31,

2021

 

 

December 31,

2020

 

Fair value hedge contracts

 

Other current assets

 

$

1,135

 

 

$

1,123

 

 

 

Other noncurrent assets

 

 

0

 

 

 

332

 

 

 

Other current liabilities

 

 

0

 

 

 

12

 

Fair value hedged items

 

Receivables

 

 

(435

)

 

 

(960

)

 

 

Other current liabilities

 

 

695

 

 

 

201

 

 

 

Other noncurrent liabilities

 

 

0

 

 

 

327

 

The change in the fair value of the cash flow contracts is recorded as a component of accumulated other comprehensive loss. The balances as of March 31, 2021, and 2020, and the amount recognized as and reclassified from accumulated other comprehensive loss for each of the periods is summarized below. Amounts are after tax, where applicable. Certain amounts recognized as comprehensive income (loss) or reclassified from accumulated other comprehensive loss have no tax effect due to the Corporation having a valuation allowance recorded against the deferred income tax assets for the jurisdiction where the income or expense is recognized.

Three Months Ended March 31, 2021

 

Beginning of

the Period

 

 

Recognized

 

 

Reclassified

 

 

End of

the Period

 

Foreign currency purchase contracts

 

$

162

 

 

$

0

 

 

$

7

 

 

$

155

 

Futures contracts – copper and aluminum

 

 

427

 

 

 

310

 

 

 

324

 

 

 

413

 

 

 

$

589

 

 

$

310

 

 

$

331

 

 

$

568

 

Three Months Ended March 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency purchase contracts

 

$

189

 

 

$

0

 

 

$

7

 

 

$

182

 

Futures contracts – copper and aluminum

 

 

102

 

 

 

(578

)

 

 

8

 

 

 

(484

)

 

 

$

291

 

 

$

(578

)

 

$

15

 

 

$

(302

)

 

The change in fair value reclassified or expected to be reclassified from accumulated other comprehensive loss to earnings is summarized below. All amounts are pre-tax.

 

 

Location of Gain (Loss)

in Statements

 

Estimated to

be Reclassified

in the Next

 

 

Three Months Ended

March 31,

 

 

 

of Operations

 

12 Months

 

 

2021

 

 

2020

 

Foreign currency purchase contracts

 

Depreciation and

amortization

 

$

28

 

 

$

7

 

 

$

7

 

Futures contracts – copper and aluminum

 

Costs of products sold

(excluding depreciation and amortization)

 

$

413

 

 

$

324

 

 

$

8

 

 

15


 

12.

Fair Value

The Corporation’s financial assets and liabilities that are reported at fair value in the condensed consolidated balance sheets as of March 31, 2021, and December 31, 2020, were as follows:

 

 

Quoted Prices

in Active

Markets for

Identical Inputs

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

 

Total

 

As of March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other noncurrent assets

 

$

4,508

 

 

$

0

 

 

$

0

 

 

$

4,508

 

Foreign currency exchange contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

0

 

 

 

(435

)

 

 

0

 

 

 

(435

)

Other current assets

 

 

0

 

 

 

1,135

 

 

 

0

 

 

 

1,135

 

Other current liabilities

 

 

0

 

 

 

695

 

 

 

0

 

 

 

695

 

As of December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other noncurrent assets

 

$

4,402

 

 

$

0

 

 

$

0

 

 

$

4,402

 

Foreign currency exchange contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

0

 

 

 

(960

)

 

 

0

 

 

 

(960

)

Other current assets

 

 

0

 

 

 

1,123

 

 

 

0

 

 

 

1,123

 

Other noncurrent assets

 

 

0

 

 

 

332

 

 

 

0

 

 

 

332

 

Other current liabilities

 

 

0

 

 

 

213

 

 

 

0

 

 

 

213

 

Other noncurrent liabilities

 

 

0

 

 

 

327

 

 

 

0

 

 

 

327

 

The investments held as other noncurrent assets represent assets held in the “Rabbi” trust for the purpose of providing benefits under the non-qualified defined benefit pension plan. The fair value of the investments is based on quoted prices of the investments in active markets. The fair value of foreign currency exchange contracts is determined based on the fair value of similar contracts with similar terms and remaining maturities. The fair value of futures contracts is based on market quotations. The fair values of the variable-rate IRB debt and borrowings under the Amended Credit Agreement approximate their carrying values. Additionally, the fair values of trade receivables and trade payables approximate their carrying values.

13.

Revenue and Income (Loss) Before Income Taxes

Net sales and income (loss) before income taxes by geographic area for the three months ended March 31, 2021, and 2020, are outlined below. When disaggregating revenue, consideration is given to information regularly reviewed by the chief operating decision maker to evaluate the financial performance of the operating segments and make resource allocation decisions. Substantially all foreign net sales for each of the periods is attributable to the FCEP segment.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Net Sales

 

 

2021

 

 

2020

 

United States

 

 

 

 

$

44,482

 

 

$

40,050

 

Foreign

 

 

 

 

 

42,318

 

 

 

51,013

 

 

 

 

 

 

$

86,800

 

 

$

91,063

 

 


16


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

Income (Loss) Before Income Taxes

 

2021

 

 

2020

 

United States (1)

 

 

 

 

 

$

(61

)

 

$

(1,340

)

Foreign

 

 

 

 

 

 

756

 

 

 

3,159

 

 

 

 

 

 

 

$

695

 

 

$

1,819

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Includes Corporate costs of $3,251 and $2,789 which represent operating costs of the corporate office not allocated to the segments.

Net sales by product line for the three months ended March 31, 2021, and 2020, were as follows:

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

2021

 

 

2020

 

Forged and cast mill rolls

 

 

 

 

$

58,166

 

 

$

65,652

 

Forged engineered products

 

 

 

 

 

5,185

 

 

 

3,112

 

Heat exchange coils

 

 

 

 

 

6,057

 

 

 

6,548

 

Centrifugal pumps

 

 

 

 

 

10,042

 

 

 

8,244

 

Air handling systems

 

 

 

 

 

7,350

 

 

 

7,507

 

 

 

 

 

 

$

86,800

 

 

$

91,063

 

 

14.

Stock-Based Compensation

The Ampco-Pittsburgh Corporation 2016 Omnibus Incentive Plan (the “Incentive Plan”) authorizes the issuance of up to 1,100,000 shares of the Corporation’s common stock for awards under the Incentive Plan. Awards under the Incentive Plan may include incentive stock options and non-qualified stock options, stock appreciation rights, restricted shares and restricted stock units, performance awards, other stock-based awards or short-term cash incentive awards. If any award is canceled, terminates, expires or lapses for any reason prior to the issuance of the shares, or if the shares are issued under the Incentive Plan and thereafter are forfeited to the Corporation, the shares subject to such awards and the forfeited shares will not count against the aggregate number of shares available under the Incentive Plan. Shares tendered or withheld to pay the option exercise price or tax withholding will continue to count against the aggregate number of shares of common stock available for grant under the Incentive Plan. Any shares repurchased by the Corporation with cash proceeds from the exercise of options will not be added back to the pool of shares available for grant under the Incentive Plan.

The Incentive Plan may be administered by the Board of Directors or the Compensation Committee of the Board of Directors. The Compensation Committee has the authority to determine, within the limits of the express provisions of the Incentive Plan, the individuals to whom the awards will be granted and the nature, amount and terms of such awards.

The Incentive Plan also provides for equity-based awards during any one year to non-employee members of the Board of Directors, based on the grant date fair value, not to exceed $200. The limit does not apply to shares received by a non-employee director at his or her election in lieu of all or a portion of the director’s retainer for board service.

Stock-based compensation expense, including expense associated with equity-based awards granted to non-employee members of the Board of Directors, for the three months ended March 31, 2021, and 2020, equaled $546 and $364, respectively. The income tax benefit recognized in the condensed consolidated statements of operations was not significant due to the Corporation having a valuation allowance recorded against its deferred income tax assets for the jurisdiction where the expense was recognized.

15.

Litigation

The Corporation and its subsidiaries are involved in various claims and lawsuits incidental to their businesses and are also subject to asbestos litigation as described below.

Asbestos Litigation

Claims have been asserted alleging personal injury from exposure to asbestos-containing components historically used in some products manufactured by predecessors of Air & Liquid (the “Asbestos Liability”). Air & Liquid, and in some cases the Corporation, are defendants (among a number of defendants, often in excess of 50) in cases filed in various state and federal courts.

17


Asbestos Claims

The following table reflects approximate information about the claims for Asbestos Liability against Air & Liquid and the Corporation for the three months ended March 31, 2021, and 2020 (claims not in thousands):

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Total claims pending at the beginning of the period

 

 

5,891

 

 

 

6,102

 

New claims served

 

 

318

 

 

 

273

 

Claims dismissed

 

 

(141

)

 

 

(86

)

Claims settled

 

 

(104

)

 

 

(108

)

Total claims pending at the end of period (1)

 

 

5,964

 

 

 

6,181

 

Administrative closures (2)

 

 

(2,887

)

 

 

 

 

Total active claims at the end of the period (2)

 

 

3,077

 

 

 

 

 

Gross settlement and defense costs paid in period (in 000’s)

 

$

3,340

 

 

$

6,206

 

Avg. gross settlement and defense costs per claim resolved (in 000’s) (3)

 

$

13.63

 

 

$

31.99

 

 

(1)

Included as “total claims pending” are approximately 687 and 749 claims in 2021 and 2020, respectively, classified in various jurisdictions as “inactive” or transferred to a state or federal judicial panel on multi-district litigation.

 

(2)

In 2021, the Corporation adopted the same methodology used by Nathan Associates, Inc. (“Nathan”), the liability expert who values the Corporation’s asbestos claims, in order to better align the Corporation’s data with Nathan’s liability valuation. Nathan’s methodology treats all claims filed six or more years ago as “administratively closed.” Therefore, the Corporation changed its prior practice of reporting “Total claims pending at the end of the period” into two categories – “Administrative closures” and “Total active claims at the end of the period.” Administrative closures now include (i) those claims that were filed six or more years ago; (ii) claims that were previously classified in various jurisdictions as “inactive;” and (iii) claims that were transferred to a state or federal judicial panel on multi-district litigation. Collectively, these claims are unlikely to result in any liability to the Corporation. Accordingly, the Corporation believes that presentation of “Total active claims at the end of the period” is a better indicator of total claims which may result in future payment.

 

(3)

Claims resolved do not include claims that were administratively closed.

A substantial majority of the settlement and defense costs reflected in the above table was reported and paid by insurers. Because claims are often filed and can be settled or dismissed in large groups, the amount and timing of settlements, as well as the number of open claims, can fluctuate significantly from period to period.

Asbestos Insurance

The Corporation and Air & Liquid are parties to a series of settlement agreements (“Settlement Agreements”) with insurers that have coverage obligations for the Asbestos Liability (the “Settling Insurers”). Under the Settlement Agreements, the Settling Insurers accept financial responsibility, subject to the terms and conditions of the respective agreements, including overall coverage limits, for pending and future claims for the Asbestos Liability. The Settlement Agreements encompass the substantial majority of insurance policies that provide coverage for claims for the Asbestos Liability.

The Settlement Agreements include acknowledgements that Howden North America, Inc. (“Howden”) is entitled to coverage under policies covering the Asbestos Liability for claims arising out of the historical products manufactured or distributed by Buffalo Forge, a former subsidiary of the Corporation (the “Products”), which was acquired by Howden. The Settlement Agreements do not provide for any prioritization on access to the applicable policies or any sublimits of liability as to Howden or the Corporation and Air & Liquid, and, accordingly, Howden may access the coverage afforded by the Settling Insurers for any covered claim arising out of the Products. In general, access by Howden to the coverage afforded by the Settling Insurers for the Products will erode coverage under the Settlement Agreements available to the Corporation and Air & Liquid for the Asbestos Liability.

Asbestos Valuations

At December 31, 2006, with the assistance of a nationally recognized expert in the valuation of asbestos liabilities, the Corporation recorded its initial reserve for the Asbestos Liability. With the assistance of the nationally recognized expert, the reserve for the Asbestos Liability had been periodically updated since that time. In 2018, the Corporation engaged Nathan Associates Inc. (“Nathan”) to update the liability valuation, and additional reserves were established by the Corporation for the Asbestos Liability claims pending or projected to be asserted through 2052, the estimated final date by which the Corporation expects to have settled all asbestos-related claims. The methodology used by Nathan in its projection was substantially the same methodology employed by the previous expert and included the following factors:

 

interpretation of a widely accepted forecast of the population likely to have been exposed to asbestos;

 

epidemiological studies estimating the number of people likely to develop asbestos-related diseases;

18


 

 

analysis of the number of people likely to file an asbestos-related injury claim against the subsidiaries and the Corporation based on such epidemiological data and relevant claims history from January 1, 2016, to August 19, 2018;

 

an analysis of pending cases, by type of injury claimed and jurisdiction where the claim is filed;

 

an analysis of claims resolution history from January 1, 2016, to August 19, 2018, to determine the average settlement value of claims, by type of injury claimed and jurisdiction of filing; and

 

an adjustment for inflation in the future average settlement value of claims, at an annual inflation rate based on the Congressional Budget Office’s forecast of inflation.

Using this information, Nathan estimated the number of future claims for the Asbestos Liability that would be filed through the year 2052, as well as the settlement or indemnity costs that would be incurred to resolve both pending and future unasserted claims through 2052. This methodology has been accepted by numerous courts.

In conjunction with developing the Asbestos Liability through 2052, the Corporation also developed an estimate of probable insurance recoveries for the Asbestos Liability. In developing the estimate, the Corporation considered Nathan’s projection for settlement or indemnity costs for the Asbestos Liability and management’s projection of associated defense costs (based on the current defense to indemnity cost ratio), as well as a number of additional factors. These additional factors included the Settlement Agreements in effect, policy exclusions, policy limits, policy provisions regarding coverage for defense costs, attachment points, prior impairment of policies and gaps in the coverage, policy exhaustions, insolvencies among certain of the insurance carriers, and the nature of the underlying claims for the Asbestos Liability asserted against the subsidiaries and the Corporation as reflected in the Corporation’s asbestos claims database, as well as estimated erosion of insurance limits on account of claims against Howden arising out of the Products. In addition to consulting with the Corporation’s outside legal counsel on these insurance matters, the Corporation consulted with a nationally recognized insurance consulting firm it retained to assist the Corporation with certain policy allocation matters that also are among the several factors considered by the Corporation when analyzing potential recoveries from relevant historical insurance for the Asbestos Liability. Based upon all of the factors considered by the Corporation, and considering the Corporation’s analysis of publicly available information regarding the credit-worthiness of various insurers, the Corporation estimated the probable insurance recoveries for the Asbestos Liability and defense costs through 2052.

Based on the analysis described above, the Corporation’s reserve at December 31, 2018, for the total costs, including defense costs, for Asbestos Liability claims pending or projected to be asserted through 2052, was $227,922. The reserve at March 31, 2021, was $176,856. Defense costs are estimated at 80% of settlement costs. The Corporation’s receivable at December 31, 2018, for insurance recoveries attributable to the claims for which the Corporation’s Asbestos Liability reserve has been established, including the portion of incurred defense costs covered by the Settlement Agreements in effect through December 31, 2018, and the probable payments and reimbursements relating to the estimated indemnity and defense costs for pending and unasserted future Asbestos Liability claims, was $152,508 ($115,862 at March 31, 2021).

The following table summarizes activity relating to insurance recoveries for the three months ended March 31, 2021, and 2020.

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Insurance receivable – asbestos, beginning of the year

 

$

117,937

 

 

$

136,932

 

Settlement and defense costs paid by insurance carriers

 

 

(2,075

)

 

 

(4,062

)

Insurance receivable – asbestos, end of the period

 

$

115,862

 

 

$

132,870

 

 

The insurance receivable recorded by the Corporation does not assume any recovery from insolvent carriers. In addition, a substantial majority of the insurance recoveries deemed probable is from insurance companies rated A – (excellent) or better by A.M. Best Corporation. There can be no assurance, however, that there will not be further insolvencies among the relevant insurance carriers, or that the assumed percentage recoveries for certain carriers will prove correct. The difference between insurance recoveries and projected costs is not due to exhaustion of all insurance coverage for the Asbestos Liability.

The amounts recorded for the Asbestos Liability and insurance receivable rely on assumptions that are based on currently known facts and strategy. The Corporation’s actual expenses or insurance recoveries could be significantly higher or lower than those recorded if assumptions used in the Corporation’s or Nathan’s calculations vary significantly from actual results. Key variables in these assumptions are identified above and include the number and type of new claims to be filed each year, the average cost of disposing of each such new claim, average annual defense costs, compliance by relevant parties with the terms of the Settlement Agreements, and the solvency risk with respect to the relevant insurance carriers. Other factors that may affect the Asbestos Liability and ability to recover under the Corporation’s insurance policies include uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, reforms that may be made by state and federal courts, and the passage of state or federal tort reform legislation.

19


The Corporation intends to evaluate the Asbestos Liability and related insurance receivable as well as the underlying assumptions on a regular basis to determine whether any adjustments to the estimates are required. Due to the uncertainties surrounding asbestos litigation and insurance, these regular reviews may result in the Corporation adjusting its current reserve; however, the Corporation is currently unable to estimate such future adjustments. Adjustments, if any, to the Corporation’s estimate of the Asbestos Liability and/or insurance receivable could be material to operating results for the periods in which the adjustments to the liability or receivable are recorded, and to the Corporation’s liquidity and consolidated financial position.

16.

Environmental Matters

The Corporation is currently performing certain remedial actions in connection with the sale of real estate previously owned and periodically incurs costs to maintain compliance with environmental laws and regulations. Environmental exposures are difficult to assess and estimate for numerous reasons, including lack of reliable data, the multiplicity of possible solutions, the years of remedial and monitoring activity required, and identification of new sites. In the opinion of management, the potential liability for remedial actions and environmental compliance measures of approximately $100 at March 31, 2021, is considered adequate based on information known to date.

17.

Business Segments

Presented below are the net sales and income before income taxes for the Corporation’s two business segments.

 

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

2021

 

 

2020

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

Forged and Cast Engineered Products

 

 

 

 

$

63,351

 

 

$

68,764

 

Air and Liquid Processing

 

 

 

 

 

23,449

 

 

 

22,299

 

Total Reportable Segments

 

 

 

 

$

86,800

 

 

$

91,063

 

Income before income taxes:

 

 

 

 

 

 

 

 

 

 

 

Forged and Cast Engineered Products

 

 

 

 

$

1,846

 

 

$

4,556

 

Air and Liquid Processing

 

 

 

 

 

2,312

 

 

 

2,584

 

Total Reportable Segments

 

 

 

 

 

4,158

 

 

 

7,140

 

Other expense, including corporate costs

 

 

 

 

 

(3,463

)

 

 

(5,321

)

Total

 

 

 

 

$

695

 

 

$

1,819

 

 

 

20


 

ITEM  2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

(in thousands, except share and per share amounts)

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by or on behalf of Ampco-Pittsburgh Corporation (the “Corporation”). Management’s Discussion and Analysis of Financial Condition and Results of Operations and other sections of this Quarterly Report on Form 10-Q, as well as the condensed consolidated financial statements and notes thereto, may include, but are not limited to, statements about operating performance, trends, events that we expect or anticipate will occur in the future, statements about sales and production levels, restructurings, the impact from global pandemics (including COVID-19), profitability and anticipated expenses, future proceeds from the exercise of outstanding warrants, and cash outflows. All statements in this document other than statements of historical fact are statements that are, or could be, deemed “forward-looking statements” within the meaning of the Act and words such as “may,” “will”, “intend,” “believe,” “expect,” “anticipate,” “estimate,” “project,” “forecast” and other terms of similar meaning that indicate future events and trends are also generally intended to identify forward-looking statements. Forward-looking statements speak only as of the date on which such statements are made, are not guarantees of future performance or expectations, and involve risks and uncertainties. For us, these risks and uncertainties include, but are not limited to:

 

cyclical demand for products and economic downturns;

 

excess global capacity in the steel industry;

 

fluctuations of the value of the U.S. dollar relative to other currencies;

 

increases in commodity prices or shortages of key production materials;

 

consequences of global pandemics (including COVID-19);

 

changes in the existing regulatory environment;

 

new trade restrictions and regulatory burdens associated with “Brexit”;

 

inability to successfully restructure our operations;

 

limitations in availability of capital to fund our operations and strategic plan;

 

inoperability of certain equipment on which we rely;

 

work stoppage or another industrial action on the part of any of our unions;

 

liability of our subsidiaries for claims alleging personal injury from exposure to asbestos-containing components historically used in certain products of our subsidiaries;

 

inability to satisfy the continued listing requirements of the New York Stock Exchange or NYSE American;

 

failure to maintain an effective system of internal control;

 

potential attacks on information technology infrastructure and other cyber-based business disruptions; and

 

those discussed more fully elsewhere in this report and in documents filed with the Securities Exchange Commission by the Corporation, particularly in Item 1A, Risk Factors, in Part I of the Corporation’s latest Annual Report on Form 10-K for the year ended December 31, 2020.

We cannot guarantee any future results, levels of activity, performance or achievements. In addition, there may be events in the future that we are not able to predict accurately or control which may cause actual results to differ materially from expectations expressed or implied by forward-looking statements. Except as required by applicable law, we assume no obligation, and disclaim any obligation, to update forward-looking statements whether as a result of new information, events or otherwise.

The Business

The Corporation manufactures and sells highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments – the Forged and Cast Engineered Products (“FCEP”) segment and the Air and Liquid Processing segment. This segment presentation is consistent with how the Corporation’s chief operating decision maker evaluates financial performance and makes resource allocation and strategic decisions about the business.


21


 

The FCEP segment produces forged hardened steel rolls, cast rolls and open-die forged products. Forged hardened steel rolls are used primarily in cold rolling mills by producers of steel, aluminum and other metals. Cast rolls, which are produced in a variety of iron and steel qualities, are used mainly in hot and cold strip mills, medium/heavy section mills and plate mills. Forged engineered products (“FEP”) are principally sold to customers in the steel distribution market, oil and gas industry and the aluminum and plastic extrusion industries. The segment has operations in the United States, England, Sweden, Slovenia, and an equity interest in three joint venture companies in China. Collectively, the segment primarily competes with European, Asian and North and South American companies in both domestic and foreign markets and distributes a significant portion of its products through sales offices located throughout the world.

The Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling and Buffalo Pumps, all divisions of Air & Liquid Systems Corporation (“Air & Liquid”), a wholly owned subsidiary of the Corporation. Aerofin produces custom-engineered finned tube heat exchange coils and related heat transfer products for a variety of industries including OEM/commercial, nuclear power generation and industrial manufacturing. Buffalo Air Handling produces large custom-designed air handling systems for institutional (e.g., hospital, university), pharmaceutical and general industrial building markets. Buffalo Pumps manufactures centrifugal pumps for the fossil-fueled power generation, marine defense and industrial refrigeration industries. The segment has operations in Virginia and New York with headquarters in Carnegie, Pennsylvania. The segment distributes a significant portion of its products through a common independent group of sales offices located throughout the United States and Canada.

COVID-19

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency caused by a new strain of the coronavirus (“COVID-19”) and advised of the risks to the international community as the virus spread globally. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in exposure globally. In response, many state and local governments required the closure of various businesses. The U.S. Department of Homeland Security, however, provided guidance identifying the Corporation’s domestic businesses as critical infrastructure industries, essential to the economic prosperity, security and continuity of the United States, which provides exceptions to certain closures mandated by state and local governments and permits businesses to continue operations during such an order. Despite the designation, the Corporation has had to periodically and temporarily idle certain operations of its FCEP segment and, consequently, furlough certain of its employees in response to market conditions. It also has experienced, and may continue to experience, customer-requested delays of deliveries or, potentially, cancellation of orders.

It is difficult to isolate the impact of the pandemic on the Corporation’s operating results, particularly in relation to the unabsorbed costs resulting from the periodic and temporary idling of certain of the Corporation’s forged and cast roll operations and furloughing of employees. In addition, the Corporation is uncertain of the full effect the pandemic will have on it for the longer term since the scope and duration of the pandemic is unknown, and evolving factors such as the level and timing of vaccine distribution across the world and the extent of any resurgences of the virus or emergence of new variants of the virus will impact the stability of the economic recovery and growth. The extent to which the operations of the Corporation, and the operations of its customers, may be adversely impacted by the COVID-19 pandemic will depend largely on these future developments. The Corporation may experience long-term disruptions to its operations resulting from changes in government policy or guidance; quarantines of employees, customers and suppliers in areas affected by the pandemic; and closures of businesses or manufacturing facilities critical to its business or supply chains. It may also incur higher write-offs of accounts receivables and impairment charges on its asset values, including property, plant and equipment and intangible assets. The Corporation is actively monitoring, and will continue to actively monitor, the pandemic and the potential impact on its operations, financial condition, liquidity, suppliers, industry, and workforce.

In response to the pandemic, the United States federal government enacted the “Coronavirus Aid, Relief, and Economic Security (CARES) Act” into law on March 27, 2020. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferral of employer-side social security payments and contributions to employee benefit plans, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. Subsequently, on March 11, 2021, the “American Rescue Plan (“ARP”) Act of 2021” was enacted into law, providing the next phase of economic relief as a result of the COVID-19 pandemic. The ARP Act, among other things, extends provision relating to refundable payroll tax credits and deferral of contributions to employee benefit plans. Similar programs have been offered in certain of the foreign jurisdictions in which the Corporation operates, including subsidies and reimbursement of certain employee-related costs. While the Corporation has taken, and intends to continue to take, advantage of various provisions of the CARES Act, the ARP Act and other similar programs offered domestically and in foreign jurisdictions in which the Corporation operates, where possible, it is unable to determine what impact those provisions may have on its consolidated financial statements in the future.

Executive Overview

For the FCEP segment, roll market conditions are improving but remain below pre-pandemic levels. Assuming no resurgences of the virus or emergence of new variants of the virus, expectations are for sales order activity to return to pre-COVID levels in the latter part of 2021 with shipments improving in 2022. The FEP market is also showing signs of improvement with increasing demand from the

22


steel distribution and oil and gas markets. The primary focus for this segment is diversification and development of FEP for use in other industries, ongoing operational and efficiency improvements at its facilities, and capital equipment investment activities to upgrade existing equipment and increase FEP capacity.

For the Air and Liquid Processing segment, Aerofin’s heat exchanger business is being adversely impacted by lower business activity in the commercial and industrial OEM markets. Buffalo Air Handling’s custom air handling business is experiencing steady demand; however, competitive pricing pressures continue. Buffalo Pumps’ specialty centrifugal pumps business is benefiting from steady demand from the marine defense market. The focus for this segment is to grow revenues, increase margins, strengthen engineering and manufacturing capabilities, increase manufacturing productivity and continue to improve its sales distribution network. To date, the Air and Liquid Processing segment has successfully mitigated the negative impact on sales and operating income resulting from the pandemic.

Consolidated Results from Operations

 

 

 

 

Three Months Ended

March 31,

 

 

 

 

 

 

2021

 

 

2020

 

Net Sales:

 

 

 

 

 

 

 

 

 

 

 

 

Forged and Cast Engineered Products

 

 

 

 

 

$

63,351

 

 

$

68,764

 

Air and Liquid Processing

 

 

 

 

 

 

23,449

 

 

 

22,299

 

Consolidated

 

 

 

 

 

$

86,800

 

 

$

91,063

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from Operations:

 

 

 

 

 

 

 

 

 

 

 

 

Forged and Cast Engineered Products

 

 

 

 

 

$

1,846

 

 

$

4,556

 

Air and Liquid Processing

 

 

 

 

 

 

2,312

 

 

 

2,584

 

Corporate costs

 

 

 

 

 

 

(3,251

)

 

 

(2,789

)

Consolidated

 

 

 

 

 

$

907

 

 

$

4,351

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

2021

 

 

December 31,

2020

 

Backlog:

 

 

 

 

 

 

 

 

 

 

 

 

Forged and Cast Engineered Products

 

 

 

 

 

$

182,150

 

 

$

191,919

 

Air and Liquid Processing

 

 

 

 

 

 

58,097

 

 

 

54,212

 

Consolidated

 

 

 

 

 

$

240,247

 

 

$

246,131

 

Net sales equaled $86,800 and $91,063 for the three months ended March 31, 2021, and 2020, respectively. The decrease of $4,263 principally is attributable to a lower volume of mill roll shipments due to reduced demand as production levels for certain customers continue to be impacted by the lingering effects of the pandemic. This decrease was offset by a higher volume of shipments of FEP to customers in the oil and gas and steel distribution markets. Additionally, shipments of centrifugal pumps increased due to a higher volume of shipments to U.S. Navy shipbuilders which were partially offset by a lower volume of shipments to the power generation industry. A discussion of sales for the Corporation’s two segments is included below.

Backlog equaled $240,247 at March 31, 2021, versus $246,131 as of December 31, 2020. Backlog represents the accumulation of firm orders on hand which: (i) are supported by evidence of a contractual arrangement, (ii) include a fixed and determinable sales price, (iii) have collectability that is reasonably assured, and (iv) generally are expected to ship within two years from the backlog reporting date. A discussion of backlog for the Corporation’s two segments is included below.

Costs of products sold, excluding depreciation and amortization, as a percentage of net sales was 80.2% and 77.0% for the three months ended March 31, 2021, and 2020, respectively. The increase is principally associated with the FCEP segment which was impacted by unabsorbed costs resulting from lower production levels due in part to the periodic and temporary idling of certain of its operations, a lower volume of mill roll shipments, higher net raw material costs, and changes in product mix. Additionally, the prior year benefited from receipt of business interruption insurance proceeds of $769 for equipment outages that occurred in 2018 (the “Proceeds from Business Interruption Insurance Claim”). For the Air and Liquid Processing segment, costs of products sold, excluding depreciation and amortization, as a percentage of net sales increased slightly as a result of product mix.

Selling and administrative expenses of $11,558 and $11,830 for the three months ended March 31, 2021, and 2020, respectively, were comparable. The impact from higher exchange rates and additional commissions, due to the increase in FEP sales, during the current year quarter was offset by lower bad debt expense. In the first quarter of 2020, the FCEP segment increased its allowance for doubtful

23


accounts by approximately $490 for anticipated write-offs for customers in the oil and gas industry anticipated to be affected by the COVID-19 pandemic.

Depreciation and amortization of $4,743 and $4,699 for the three months ended March 31, 2021, and 2020, respectively, were comparable.

Income from operations equaled $907 and $4,351 for the three months ended March 31, 2021, and 2020, respectively. The prior year period includes the Proceeds from Business Interruption Insurance Claim.

Investment-related income of $18 and $4 for the three months ended March 31, 2021, and 2020, respectively, were comparable.

Interest expense equaled $895 and $1,216 for the three months ended March 31, 2021, and 2020, respectively. The decrease is principally due to lower average borrowings outstanding under the revolving credit facility in 2021 compared to 2020.

Other income (expense) – net equaled $665 and $(1,320) for the three months ended March 31, 2021, and 2020, respectively. The improvement is due to:

 

Lower foreign exchange losses of $510;

 

Changes in the unrealized gains and losses on Rabbi trust investments of $893 principally due to market volatility in the prior year associated with the COVID-19 pandemic; and

 

Higher pension income of $582 due to lower interest costs on employee benefit obligations as a result of lower discount rates in effect as of the beginning of the year when compared to a year ago coupled with a higher expected return on plan assets in the current year as a result of an increase in the fair value of plan assets year over year.

Income tax (provision) benefit for each of the periods includes income taxes associated with the Corporation’s profitable operations. An income tax benefit is not able to be recognized on losses of certain of the Corporation’s entities since it is “more likely than not” the asset will not be realized. The fluctuation between the periods is principally attributable to a $3,502 benefit recorded in the first quarter of 2020 due to the CARES Act, which enabled the Corporation to carry back net operating losses to an earlier period, at a higher tax rate, and to release a portion of the valuation allowance it had previously established against its deferred income tax assets.

Net income attributable to Ampco-Pittsburgh and income per common share for the three months ended March 31, 2020, include an income tax benefit of $3,502, due to the enactment of the CARES Act, and the Proceeds from Business Interruption Insurance Claim, which had a combined positive impact on income per common share of $0.34.

Net Sales and Operating Results by Segment

Forged and Cast Engineered Products

 

 

 

 

Three Months Ended

March 31,

 

 

 

 

 

 

2021

 

 

2020

 

Net Sales

 

 

 

 

 

$

63,351

 

 

$

68,764

 

Income from Operations

 

 

 

 

 

$

1,846

 

 

$

4,556

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

2021

 

 

December 31,

2020

 

Backlog

 

 

 

 

 

$

182,150

 

 

$

191,919

 

Net sales approximated $63,351 and $68,764 for the three months ended March 31, 2021, and 2020, respectively. The decrease of $5,413 from the prior year period is principally due to:

 

Lower volume of shipments of mill rolls due to reduced demand as certain customers’ production levels continue to be impacted by the lingering effects of the pandemic, which reduced net sales by approximately $8,800; and

 

Unfavorable product mix, net of higher variable-index surcharges passed through to customers as a result of higher raw material costs, which reduced net sales by approximately $2,400; offset by

 

Higher volume of FEP shipments as a result of increased demand from the steel distribution and oil and gas markets, which increased net sales by $2,700;

 

Changes in exchanges rates used to translate net sales of the segment’s foreign subsidiaries into the U.S. dollar, which increased net sales by approximately $3,100.   

24


Operating results approximated $1,846 and $4,556 for the three months ended March 31, 2021, and 2020, respectively, a decrease of $2,710. Operating results for the prior year included:

 

Proceeds from the Business Interruption Insurance Claim of $769 received in the first quarter of 2020; offset by

 

Charges for anticipated bad debts and slow-moving inventory reserves of approximately $1,000 in the first quarter of 2020 for customers expected to be more severely impacted by the pandemic.

Operating results also fluctuated due to:

 

Lower cost absorption due to reduced production levels, which adversely effected operating results by approximately $1,300;

 

Net lower volume of shipments, which adversely impacted operating results by approximately $1,200;

 

Higher raw material costs, net of higher variable-index surcharges passed through to customers, which adversely impacted operating results by approximately $700; and

 

Unfavorable product mix, which adversely impacted earnings by approximately $500; offset by

 

Lower selling and administrative expenses of approximately $500; and

 

Changes in exchanges rates used to translate operating results of the segment’s foreign subsidiaries into the U.S. dollar, which increased operating income by approximately $400.  

Backlog equaled $182,150 at March 31, 2021, compared to $191,919 at December 31, 2020. The decrease in backlog is principally due to lower backlog for forged and cast rolls as a result of customers postponing order placement given the uncertainty surrounding the pandemic. An overall increase in foreign exchange rates used to translate the backlog of the Corporation’s foreign subsidiaries into the U.S. dollar and higher backlog for FEP due to improved demand helped to offset the decrease from December 31, 2020. At March 31, 2021, the majority of the backlog is expected to ship in 2021.

Air and Liquid Processing

 

 

 

 

Three Months Ended

March 31,

 

 

 

 

 

 

2021

 

 

2020

 

Net Sales

 

 

 

 

 

$

23,449

 

 

$

22,299

 

Income from Operations

 

 

 

 

 

$

2,312

 

 

$

2,584

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

2021

 

 

December 31,

2020

 

Backlog

 

 

 

 

 

$

58,097

 

 

$

54,212

 

Net sales approximated $23,449 and $22,299 for the three months ended March 31, 2021, and 2020, respectively, an increase of $1,150. Sales of pumps improved from a year ago by approximately 21.8% and benefited from a higher volume of shipments to U.S. Navy shipbuilders which were partially offset by lower shipments to the power generation industry. By comparison, sales of heat exchange coils decreased from a year ago by approximately 7.5% and were negatively impacted by a lower volume of replacement business. Sales of air handling units were relatively comparable quarter over quarter. Operating income for the quarter decreased slightly when compared to the prior year quarter primarily due to product mix. Backlog at March 31, 2021, improved to $58,097 from $54,212 at December 31, 2020, principally as a result of improved order intake for air handling units for the hospital and pharmaceutical markets. At March 31, 2021, the majority of the backlog is expected to ship in 2021.

Non-GAAP Financial Measures

The Corporation presents non-GAAP adjusted income from operations, which is calculated as income from operations excluding the Proceeds from Business Interruption Insurance Claim. This non-GAAP financial measure is not based on any standardized methodology prescribed by accounting principles generally accepted in the United States of America (“GAAP”) and may not be comparable to similarly-titled measures presented by other companies.

The Corporation has presented non-GAAP adjusted income from operations because it is a key measure used by the Corporation’s management and Board of Directors to understand and evaluate the Corporation’s operating performance and to develop operational goals for managing its business. This non-GAAP financial measure excludes significant charges or credits, that are one-time charges or credits, unrelated to the Corporation’s ongoing results of operations or beyond its control. Additionally, a portion of the incentive and compensation arrangements for certain employees is based on the Corporation’s business performance. The Corporation believes this non-GAAP financial measure helps identify underlying trends in its business that could otherwise be masked by the effect of the items that it excludes from adjusted income from operations. The Corporation also believes this non-GAAP financial measure

25


provides useful information to management, shareholders and investors, and others in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects and allowing for greater transparency with respect to key financial metrics used by the Corporation’s management in its financial and operational decision-making.

Adjusted income from operations is not prepared in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are limitations related to the use of adjusted income from operations rather than income from operations, which is the nearest GAAP equivalent. Among other things, there can be no assurance that additional benefits similar to the Proceeds from Business Interruption Insurance Claim will not occur in future periods.

The adjustments reflected in adjusted income from operations are pre-tax. There is no tax impact associated with these adjustments due to the Corporation having a valuation allowance recorded against the deferred income tax assets for the jurisdictions where the income or expense is recognized.

The following is a reconciliation of income from operations to non-GAAP adjusted income from operations for the three months ended March 31, 2021, and 2020, respectively:

 

 

 

 

Three Months Ended

March 31,

 

 

 

 

 

 

 

2021

 

 

2020

 

Income from operations, as reported (GAAP)

 

 

 

 

 

$

907

 

 

$

4,351

 

Proceeds from Business Interruption Insurance Claim (1)

 

 

 

 

 

 

0

 

 

 

(769

)

Income from operations, as adjusted (Non-GAAP)

 

 

 

 

 

$

907

 

 

$

3,582

 

 

(1)

Represents business interruption insurance proceeds received for equipment outages that occurred in 2018.

Liquidity and Capital Resources

Net cash flows provided by operating activities for the three months ended March 31, 2021, and 2020, equaled $1,858 and $12,605, respectively. The decrease between the periods is principally due to an increase in trade working capital as the Corporation begins to return to a higher level of business activity following the pandemic.

Deferred employer-side social security payments equaled $2,163 at March 31, 2021. Under the current provisions of the CARES Act, deferred social security payments will be due equally in December 2021 and December 2022.

Net cash flows used in investing activities equaled $2,303 and $1,843 for the three months ended March 31, 2021, and 2020, respectively. Capital expenditures for each of the periods were comparable and related primarily to the FCEP segment. As of March 31, 2021, commitments for future capital expenditures approximated $3,700, which are expected to be spent over the next 12 – 18 months. In addition, the Corporation will be undertaking a significant capital program valued between $25,000 and $30,000 to upgrade existing equipment at certain of its FCEP locations which is anticipated to occur over the next three years.

Net cash flows provided by (used in) financing activities equaled $2,172 and $(3,144) for the three months ended March 31, 2021, and 2020, respectively. The improvement of $5,316 is primarily due to proceeds of $3,101 received in the current year as a result of shareholders exercising their warrants for the Corporation’s common stock and lower net repayments of borrowings from the Corporation’s revolving credit agreement of $2,380.

As a result of the above, cash and cash equivalents increased by $1,409 in 2021 and ended the period at $18,251 in comparison to $16,842 at December 31, 2020. As of March 31, 2021, the majority of the Corporation’s cash and cash equivalents is held by the Corporation’s foreign operations. Domestic customer remittances are used to pay down borrowings under the Corporation’s revolving credit facility daily, resulting in minimal cash maintained by the Corporation’s domestic operations. Cash held by the Corporation’s foreign operations is considered to be permanently reinvested; accordingly, a provision for estimated local and withholding tax has not been made. If the Corporation were to remit any foreign earnings to it or any of its U.S. entities, the estimated tax impact would be insignificant.

Funds on hand, funds generated from future operations and availability under the Corporation’s revolving credit facility are expected to be sufficient to finance the Corporation’s operational and capital expenditure requirements. The maturity date for the revolving credit facility is May 20, 2022, and, subject to the other terms and conditions of the revolving credit agreement, will become due on that date. The Corporation intends to negotiate a longer-term arrangement prior to the maturity of the revolving credit facility. While availability under the revolving credit facility also should be sufficient to fund the capital equipment investment activities for the FCEP segment over the next few years, the Corporation is exploring potential financing alternatives. As of March 31, 2021, remaining availability under the revolving credit facility approximated $46,800, net of standard availability reserves.


26


 

Litigation and Environmental Matters

See Note 15 and Note 16 to the condensed consolidated financial statements.

Critical Accounting Pronouncements

The Corporation’s critical accounting policies, as summarized in its Annual Report on Form 10-K for the year ended December 31, 2020, remain unchanged.

Recently Issued Accounting Pronouncements

See Note 1 to the condensed consolidated financial statements.

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

 

ITEM 4 – CONTROLS AND PROCEDURES

(a)

Disclosure controls and procedures. An evaluation of the effectiveness of the Corporation’s disclosure controls and procedures as of the end of the period covered by this report was carried out under the supervision, and with the participation, of management, including the principal executive officer and principal financial officer. Disclosure controls and procedures are defined under Securities and Exchange Commission (“SEC”) rules as controls and other procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) is recorded, processed, summarized and reported within the required time periods. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, the Corporation’s management, including the principal executive officer and principal financial officer, has concluded that the Corporation’s disclosure controls and procedures were effective as of March 31, 2021.

(c)

Changes in Internal Control. There has been no change in the Corporation’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Exchange Act that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

27


PART II – OTHER INFORMATION

AMPCO-PITTSBURGH CORPORATION

Item  1

Legal Proceedings

The information contained in Note 15 to the condensed consolidated financial statements (Litigation) is incorporated herein by reference.

Item  1A

Risk Factors

There are no material changes to the Risk Factors contained in Item 1A to Part I of the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2020.

Items 2-5

None


28


 

Item  6

Exhibits

 

 

 

 

 

 

(3.1)

 

Restated Articles of Incorporation, effective as of August 11, 2017, incorporated by reference to Quarterly Report on Form 10-Q filed on November 9, 2017.

 

 

 

(3.2)

 

Amended and Restated By-laws, effective as of December 17, 2015, incorporated by reference to Current Report on Form 8-K filed on December 23, 2015.

 

 

 

(3.3)

 

Amendment of Amended and Restated Articles of Incorporation, effective as of May 9, 2019, incorporated by reference to Quarterly Report on Form 10-Q filed on May 10, 2019.

 

 

 

(31.1)

 

Certification of Principal Executive Officer pursuant to Section 302 of The Sarbanes-Oxley Act of 2002.

 

 

 

(31.2)

 

Certification of Principal Financial Officer pursuant to Section 302 of The Sarbanes-Oxley Act of 2002.

 

 

 

(32.1)

 

Certification of Principal Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.

 

 

 

(32.2)

 

Certification of Principal Financial Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.

 

 

 

(101)

 

Interactive Data File (XBRL)

 

29


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

AMPCO-PITTSBURGH CORPORATION

 

 

 

 

 

DATE: May 10, 2021

 

BY:

 

/s/ J. Brett McBrayer

 

 

 

 

J. Brett McBrayer

 

 

 

 

Director and Chief Executive Officer

 

 

 

 

 

DATE: May 10, 2021

 

BY:

 

/s/ Michael G. McAuley

 

 

 

 

Michael G. McAuley

 

 

 

 

Senior Vice President, Chief Financial Officer and Treasurer

 

 

 

 

30